Milestone Drug Patent Portfolio
Milestone owns 1 orange book drug protected by 6 US patents Given below is the list of Milestone's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12257224 | Methods Of Administration For Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker | 15 Jul, 2042 | Active |
| US10117848 | Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof | 13 Apr, 2036 | Active |
| US10010522 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof | 19 Jun, 2028 | Active |
| US10010523 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof | 19 Jun, 2028 | Active |
| US9227918 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof | 19 Jun, 2028 | Active |
| US9463179 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof | 19 Jun, 2028 | Active |
Latest Legal Activities on Milestone's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Milestone.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Change in Power of Attorney (May Include Associate POA) | 15 Apr, 2025 | US9463179 |
| Change in Power of Attorney (May Include Associate POA) | 15 Apr, 2025 | US9227918 |
| Email Notification | 15 Apr, 2025 | US9463179 |
| Email Notification | 15 Apr, 2025 | US9227918 |
| Change in Power of Attorney (May Include Associate POA) | 14 Apr, 2025 | US10010523 |
| Email Notification | 14 Apr, 2025 | US10010522 |
| Email Notification | 14 Apr, 2025 | US10010523 |
| Change in Power of Attorney (May Include Associate POA) | 14 Apr, 2025 | US10010522 |
| Patent Issue Date Used in PTA Calculation | 25 Mar, 2025 | US12257224 |
| Mail Patent eGrant Notification | 25 Mar, 2025 | US12257224 |
| Recordation of Patent Grant Mailed | 25 Mar, 2025 | US12257224 |
| Recordation of Patent eGrant | 25 Mar, 2025 | US12257224 |
| Email Notification | 25 Mar, 2025 | US12257224 |
| Patent eGrant Notification | 25 Mar, 2025 | US12257224 |
| Issue Notification Mailed | 05 Mar, 2025 | US12257224 |
Milestone's Family Patents
Milestone Drug List
Given below is the complete list of Milestone's drugs and the patents protecting them.
1. Cardamyst
Cardamyst is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12257224 | Methods Of Administration For Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker |
15 Jul, 2042
(16 years from now)
| Active |
| US10117848 | Highly Water-Soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof |
13 Apr, 2036
(10 years from now)
| Active |
| US10010522 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof |
19 Jun, 2028
(2 years from now)
| Active |
| US10010523 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof |
19 Jun, 2028
(2 years from now)
| Active |
| US9227918 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof |
19 Jun, 2028
(2 years from now)
| Active |
| US9463179 | Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof |
19 Jun, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cardamyst's drug page